According to some studies, an increase in Akap1 has been detected in cancer patients [34, 35], with studies demonstrating that Akap1, which is a target of proto-oncogene, Myc, stimulates the mTOR pathway[33], resulting in the development of cancer. Here, MYC is linked to cancer.